2024-12-08 - Analysis Report
## Johnson & Johnson (JNJ) Stock Review

**1. Performance Comparison & Divergence:**

Johnson & Johnson (JNJ), a multinational healthcare company that manufactures pharmaceuticals, medical devices, and consumer packaged goods, significantly underperformed the S&P 500 (VOO) over the measured period.  The cumulative return for JNJ is 27.64%, while VOO's is 122.19%. This represents a difference of -94.5 percentage points.  The provided relative divergence metric of 0.0 indicates that this underperformance is at the lower extreme of the historical range observed in the data.


**2. Recent Price Movement:**

* **Closing Price:** $149.31
* **5-day Moving Average:** $151.29
* **20-day Moving Average:** $152.81
* **60-day Moving Average:** $158.11

The stock price is currently trading below all three moving averages, suggesting a potential short-term downtrend.  The closing price of 149.25 is not significantly different from the reported closing price of 149.31, so no significant recent price jump or drop is evident.


**3. Technical Indicators & Expected Return:**

* **RSI (Relative Strength Index):** 36.6 – This indicates the stock is currently in oversold territory.
* **PPO (Percentage Price Oscillator):** -0.15 –  Suggests bearish momentum.
* **Recent Relative Divergence:** -1.1 – Shows a recent short-term downward trend.
* **Expected Return:** 0.0% –  The provided data suggests no significant outperformance relative to the S&P 500 is expected over the long term (2+ years) with a buy-and-hold strategy.


**4. Recent Earnings Analysis:**

The provided earnings data reveals inconsistent quarterly performance:

* **Revenue:** Revenue fluctuates around $21-22.5 Billion, showing minimal growth. There's no clear upward trend.
* **EPS (Earnings Per Share):** EPS is highly volatile.  The significant jump in EPS from Q3 2023 ($10.32) to Q4 2023 ($1.68) followed by more moderate and declining values after that requires further investigation to understand the underlying causes.  Without additional information, it's impossible to determine if these fluctuations were due to exceptional items or normal business variations.  Analyzing individual quarterly performance against prior year-over-year numbers is important for more comprehensive analysis.


**5. Financial Information Analysis:**

* **Revenue and Profitability:** Revenue remains relatively stable, but profit margins fluctuate slightly around 69%, suggesting consistent profitability despite slight variations.
* **Capital and Profitability:** Equity varies, and ROE (Return on Equity) is highly inconsistent, ranging from 3.84% to a strikingly high 36.54% in Q3 2023. This extreme variation needs additional data and context to be understood.  It highlights a potential need for further investigation into specific accounting practices and business factors in a specific quarter.


**6. News and Recent Issues:**

No specific news or analyst opinions are provided in the given data.  To get a full picture, additional research on recent news headlines and analyst reports is recommended.


**7. Overall Analysis:**

JNJ has significantly underperformed the S&P 500 recently. While the RSI suggests the stock might be oversold, other indicators point towards a bearish trend. The recent earnings reports show volatility in both revenue and EPS, with the latter requiring further exploration.  The highly inconsistent ROE raises further concerns.  Before making any investment decisions, more detailed financial analysis and up-to-date news are essential, including the context surrounding the unusual spike in Q3 2023 ROE. The provided data alone is insufficient to give a strong buy or sell recommendation.


**8. Disclaimer:** This analysis is based solely on the provided data and is not financial advice.  Independent research and consultation with a financial advisor are highly recommended before making any investment decisions.  This analysis does not include consideration for an investor's personal risk tolerance or financial goals.
